Showing results (61-70 of 75) with videos related to
Sort By:
Pageof 8
American Journal of Health Behavior|June 9, 2007
Effects of individual components of multiple behavior changes: the PREMIER trialEva Obarzanek, William M Vollmer, Pao-Hwa Lin, et al.Obesity (Silver Spring, Md.)|January 10, 2023
Neighborhood deprivation and residential property values do not affect weight loss at 1 or 3 years after bariatric surgeryAdam Drewnowski, Benjamin D Hong, Ernest Shen, et al.International Journal of Environmental Research and Public Health|February 25, 2022
Physical Activity Levels and Screen Time among Youth with Overweight/Obesity Using Mental Health ServicesGerald J Jerome, Tyler Fink, Tammy Brady, et al.Obesity Surgery|August 23, 2023
Baseline Psychosocial, Environmental, Health, and Behavioral Correlates of 1- and 3-Year Weight Loss After Bariatric SurgeryMing Ji, Sonya L Negriff, Jeff M Slezak, et al.Frontiers in Psychiatry|February 26, 2019
Need for Cardiovascular Risk Reduction in Persons With Serious Mental Illness: Design of a Comprehensive InterventionArlene T Dalcin, Gerald J Jerome, Lawrence J Appel, et al.JAMA Psychiatry|June 28, 2023
Effect of a Tobacco Cessation Intervention Incorporating Weight Management for Adults With Serious Mental Illness: A Randomized Clinical TrialGail L Daumit, A Eden Evins, Corinne Cather, et al.BMJ Open|May 25, 2022
Cohort profile: The Bariatric Experience Long Term (BELONG): a long-term prospective study to understand the psychosocial, environmental, health and behavioural predictors of weight loss and regain in patients who have bariatric surgeryKaren J Coleman, Silvia R Paz, Bhumi B Bhakta, et al.BMC Cancer|February 26, 2022
The Kaiser Permanente Research Bank Cancer Cohort: a collaborative resource to improve cancer care and survivorshipHeather Spencer Feigelson, Christina L Clarke, Stephen K Van Den Eeden, et al.JAMA Network Open|June 13, 2020
Effect of a Comprehensive Cardiovascular Risk Reduction Intervention in Persons With Serious Mental Illness: A Randomized Clinical TrialGail L Daumit, Arlene T Dalcin, Faith B Dickerson, et al.Contemporary Clinical Trials|January 10, 2026
The long-term effectiveness of the anti-obesity medication phentermine (LEAP) trial: Rationale, design, and baseline characteristicsCaroline Blackwell Young, Emily Rives, Kimberly A Gudzune, et al.Pageof 8